SECURITIES AND EXCHANGE COMMISSION
FORM 10-Q
| [X] | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE | |
| SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended February 1, 2004 or
| [ ] |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to .
0-21488
CATALYST SEMICONDUCTOR, INC.
| Delaware (State or other jurisdiction of incorporation or organization) |
77-0083129 (I.R.S. Employer Identification No.) |
|
| 1250 Borregas Avenue Sunnyvale, California (Address of Registrants principal executive offices) |
94089 (Zip Code) |
(408) 542-1000
Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o
Indicate by check mark whether the Registrant is an accelerated filer (as defined in Rule 12(b)(2) of the Exchange Act). Yes x No o
The number of shares outstanding of the Registrants Common Stock as of February 13, 2004 was 16,703,114 exclusive of 3,044,100 shares of treasury stock.
CATALYST SEMICONDUCTOR, INC.
TABLE OF CONTENTS
| Page | ||||
PART I. |
FINANCIAL INFORMATION |
|||
Item 1. |
Consolidated Financial Statements |
|||
Unaudited Condensed Consolidated Balance Sheets
at January 31, 2004 and April 30, 2003
|
3 |
|||
Unaudited Condensed Consolidated Statements of Operations for the three and nine
month periods ended January 31, 2004 and 2003
|
4 |
|||
Unaudited Condensed Consolidated Statements of Cash Flows for the nine
month periods ended January 31, 2004 and 2003
|
5 |
|||
Notes to Unaudited Condensed Consolidated Financial Statements
|
6 |
|||
Item 2. |
Managements Discussion and Analysis of Financial Condition and
Results of Operations
|
13 |
||
Item 3. |
Quantitative and Qualitative Disclosures About Market Risk
|
29 |
||
Item 4. |
Controls and Procedures
|
29 |
||
PART II. |
OTHER INFORMATION |
|||
Item 1. |
Legal Proceedings
|
30 |
||
Item 4. |
Submission of Matters to a Vote of Security Holder
|
30 |
||
Item 6. |
Exhibits and Reports on Form 8-K
|
30 |
||
SIGNATURES |
31 |
|||
EXHIBIT INDEX |
32 |
|||
CERTIFICATIONS |
33-35 |
2
PART I FINANCIAL INFORMATION
Item 1. Consolidated Financial Statements
CATALYST SEMICONDUCTOR, INC.
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands)
| January 31, | April 30, | |||||||||||
| 2004 | 2003 | |||||||||||
ASSETS |
||||||||||||
Current assets: |
||||||||||||
Cash and cash equivalents |
$ | 18,604 | $ | 7,828 | ||||||||
Short term investments |
16,247 | 20,078 | ||||||||||
Accounts receivable, net |
10,275 | 7,863 | ||||||||||
Inventories, net |
6,876 | 8,423 | ||||||||||
Deferred tax assets |
1,914 | 1,914 | ||||||||||
Other assets |
844 | 1,146 | ||||||||||
Total current assets |
54,760 | 47,252 | ||||||||||
Property and equipment, net |
3,022 | 3,091 | ||||||||||
Other assets |
271 | 245 | ||||||||||
Total assets |
$ | 58,053 | $ | 50,588 | ||||||||
LIABILITIES AND STOCKHOLDERS EQUITY |
||||||||||||
Current liabilities: |
||||||||||||
Accounts payable |
$ | 4,485 | $ | 3,674 | ||||||||
Accounts payablerelated party |
429 | 18 | ||||||||||
Accrued expenses |
3,623 | 3,126 | ||||||||||
Deferred gross profit on shipments to distributors |
2,614 | 1,417 | ||||||||||
Total current liabilities |
11,151 | 8,235 | ||||||||||
Commitments and Contingencies (Note 8) |
||||||||||||
Stockholders equity: |
||||||||||||
Preferred stock, $.001 par value, 2,000 shares authorized; no shares
issued or outstanding |
| | ||||||||||
Common stock, $.001 par value, 45,000 shares authorized; 19,739
issued and 16,695 outstanding at January 31, 2004 and 19,247 shares
issued and 16,285 outstanding at April 30, 2003 |
20 | 19 | ||||||||||
Additional paid in capital |
53,644 | 52,632 | ||||||||||
Treasury stock, 3,044 at January 31, 2004 and 2,962 at April 30, 2003 |
(8,555 | ) | (8,340 | ) | ||||||||
Retained earnings (Accumulated deficit) |
1,782 | (1,985 | ) | |||||||||
Accumulated other comprehensive income |
11 | 27 | ||||||||||
Total stockholders equity |
46,902 | 42,353 | ||||||||||
Total liabilities and stockholders equity |
$ | 58,053 | $ | 50,588 | ||||||||
See accompanying notes to the unaudited condensed consolidated financial statements.
3
CATALYST SEMICONDUCTOR, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share data)
| Three Months Ended | Nine Months Ended | ||||||||||||||||
| January 31, | January 31, | January 31, | January 31, | ||||||||||||||
| 2004 | 2003 | 2004 | 2003 | ||||||||||||||
Net revenues |
$ | 16,875 | $ | 11,207 | $ | 46,700 | $ | 35,711 | |||||||||
Cost of revenues |
9,108 | 7,089 | 28,795 | 21,182 | |||||||||||||
Gross profit |
7,767 | 4,118 | 17,905 | 14,529 | |||||||||||||
Research and development |
1,936 | 1,269 | 5,134 | 3,753 | |||||||||||||
Selling, general and administrative |
2,984 | 2,451 | 8,515 | 7,333 | |||||||||||||
Income from operations |
2,847 | 398 | 4,256 | 3,443 | |||||||||||||
Interest income, net |
108 | 83 | 282 | 237 | |||||||||||||
Income before income taxes |
2,955 | 481 | 4,538 | 3,680 | |||||||||||||
Income tax provision |
534 | 167 | 771 | 1,363 | |||||||||||||
Net income |
$ | 2,421 | $ | 314 | $ | 3,767 | $ | 2,317 | |||||||||
Net income per share: |
|||||||||||||||||
Basic |
$ | 0.15 | $ | 0.02 | $ | 0.23 | $ | 0.14 | |||||||||
Diluted |
$ | 0.12 | $ | 0.02 | $ | 0.19 | $ | 0.13 | |||||||||
Weighted average common shares: |
|||||||||||||||||
Basic |
16,620 | 16,774 | 16,487 | 16,813 | |||||||||||||
Diluted |
19,890 | 18,176 | 19,351 | 18,492 | |||||||||||||
See accompanying notes to the unaudited condensed consolidated financial statements.
4
CATALYST SEMICONDUCTOR, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
| Nine Months Ended | ||||||||||||
| January 31, | January 31, | |||||||||||
| 2004 | 2003 | |||||||||||
Cash flows from operating activities: |
||||||||||||
Net income |
$ | 3,767 | $ | 2,317 | ||||||||
Adjustments to reconcile net income to net cash provided by
operating activities: |
||||||||||||
Depreciation of property and equipment |
1,049 | 787 | ||||||||||
Benefit from sale of inventory previously reserved |
(1,583 | ) | (2,237 | ) | ||||||||
Provision for excess and obsolete inventory |
705 | 2,181 | ||||||||||
Loss on the sale of fixed assets |
28 | 11 | ||||||||||
Changes in assets and liabilities: |
||||||||||||
Accounts receivable |
(2,412 | ) | 1,486 | |||||||||
Inventories |
2,425 | 892 | ||||||||||
Other assets |
276 | 517 | ||||||||||
Accounts payable (including related party) |
1,222 | (777 | ) | |||||||||
Accrued expenses |
663 | 1,070 | ||||||||||
Deferred gross profit on shipments to distributors |
1,197 | (184 | ) | |||||||||
Net cash provided by operating activities |
7,337 | 6,063 | ||||||||||
Cash flows from investing activities: |
||||||||||||
Sale (purchase) of short-term investments |
3,815 | (7,964 | ) | |||||||||
Acquisition of property and equipment |
(1,008 | ) | (1,044 | ) | ||||||||
Net cash provided by (used in) investing activities |
2,807 | (9,008 | ) | |||||||||
Cash flows from financing activities: |
||||||||||||
Common stock issuances |
847 | 227 | ||||||||||
Treasury stock purchases |
(215 | ) | (1,659 | ) | ||||||||
Net cash provided by (used in) financing activities |
632 | (1,432 | ) | |||||||||
Net increase (decrease) in cash and cash equivalents |
10,776 | (4,377 | ) | |||||||||
Cash and cash equivalents at beginning of the period |
7,828 | 26,295 | ||||||||||
Cash and cash equivalents at end of the period |
$ | 18,604 | $ | 21,918 | ||||||||
See accompanying notes to the unaudited condensed consolidated financial statements.
5
CATALYST SEMICONDUCTOR, INC.
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Note 1 - Basis of Presentation:
In the opinion of the management of Catalyst Semiconductor, Inc. (Company), the unaudited condensed consolidated interim financial statements included herein have been prepared on the same basis as the Companys April 30, 2003 audited consolidated financial statements and include all adjustments, consisting of only normal recurring adjustments, necessary to fairly state the information set forth herein. The consolidated statements include the accounts of the Companys wholly owned subsidiaries, Nippon Catalyst KK (NCKK), a sales organization in Japan and Catalyst Semiconductor Romania SRL (CSR), a design center in Europe. All material intercompany balances have been eliminated. The statements have been prepared in accordance with the regulations of the Securities and Exchange Commission (SEC). For further information, refer to the consolidated financial statements and footnotes thereto included in the Companys Annual Report on Form 10-K for the year ended April 30, 2003. The results of operations for the three and nine month periods ended January 31, 2004 are not necessarily indicative of the results to be expected for the entire year ending April 30, 2004 or any other future period. Certain prior period balances have been reclassified to conform to the current period presentation.
The Companys business is highly cyclical and has been subject to significant downturns at various times which have been characterized by reduced product demand, production overcapacity and significant erosion of average selling prices.
Occasionally, periods of significant upturns occur during which foundry capacity is limited resulting in shortages and increased inventory costs.
The Companys fiscal year is the 52 or 53-week period ending on the Sunday closest to April 30. In a 52-week year, each fiscal quarter consists of 13 weeks. Fiscal year 2004 will be comprised of 53 weeks with the extra week added to the third quarter making it consist of 14 weeks. For presentation purposes only, the financial statements and notes refer to April 30 as the Companys year-end and July 31, October 31 and January 31 as the Companys quarter-ends.
In December 2002, the Financial Accounting Standards Board (FASB) issued Statement of Financial Accounting Standards (SFAS) No. 148, Accounting for Stock-Based Compensation, Transition and Disclosure which amended SFAS No. 123 (SFAS 123) requiring that disclosures of the pro forma effect use the fair value method of accounting for stock-based employee compensation be displayed more prominently, in a tabular format and on a quarterly basis. The following table illustrates the effect on the Companys net income and net income per share if compensation costs had been recorded based on the estimated fair value as of the grant date as defined by SFAS 123 for all granted stock-based awards.
| Three Months Ended | Nine Months Ended | |||||||||||||||
| January 31, | January 31, | January 31, | January 31, | |||||||||||||
| 2004 | 2003 | 2004 | 2003 | |||||||||||||
| (In thousands, except per share amounts) | ||||||||||||||||
Reported net income |
$ | 2,421 | $ | 314 | $ | 3,767 | $ | 2,317 | ||||||||
Add: Stock-based employee compensation expense included in
reported net income, net of
tax |
| 10 | | 57 | ||||||||||||
Deduct: Stock-based employee compensation expense determined
under fair value based method for all awards, net of
tax |
(1,012 | ) | (640 | ) | (2,443 | ) | (2,000 | ) | ||||||||
Pro forma net income
(loss) |
$ | 1,409 | $ | (316 | ) | $ | 1,324 | $ | 374 | |||||||
Pro forma net income (loss) per share: |
||||||||||||||||
Basic |
$ | 0.08 | $ | (0.02 | ) | $ | 0.08 | $ | 0.02 | |||||||
Diluted |
$ | 0.07 | $ | (0.02 | ) | $ | 0.07 | $ | 0.02 | |||||||
6
CATALYST SEMICONDUCTOR, INC.
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Note 2 Net Income Per Share:
Basic net income per share is computed by dividing net income available to common stockholders (numerator) by the weighted average number of common shares outstanding (denominator) during the period and excludes the dilutive effect of stock options. Diluted net income per share gives effect to all dilutive potential common shares outstanding during a period. In computing diluted net income per share, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options.
A reconciliation of the numerators and denominators of the basic and diluted income per share is presented in the following table (in thousands, except per share data):
| Three Months Ended | Nine Months Ended | |||||||||||||||
| January 31, | January 31, | January 31, | January 31, | |||||||||||||
| 2004 | 2003 | 2004 | 2003 | |||||||||||||
Reported net income |
$ | 2,421 | $ | 314 | $ | 3,767 | $ | 2,317 | ||||||||
Shares calculation: |
||||||||||||||||
Weighted average shares outstandingbasic |
16,620 | 16,774 | 16,487 | 16,813 | ||||||||||||
Effect of dilutive securities: |
||||||||||||||||
Stock options |
3,270 | 1,402 | 2,864 | 1,679 | ||||||||||||
Weighted average shares outstandingdiluted |
19,890 | 18,176 | 19,351 | 18,492 | ||||||||||||
Reported net income per share: |
||||||||||||||||
Basic |
$ | 0.15 | $ | 0.02 | $ | 0.23 | $ | 0.14 | ||||||||
Diluted |
$ | 0.12 | $ | 0.02 | $ | 0.19 | $ | 0.13 | ||||||||
Options to purchase 151,000 shares of common stock at a weighted average exercise price of $8.32 per share outstanding during the quarter ended January 31, 2004 and options to purchase 1,168,000 shares of common stock at a weighted average exercise price of $6.15 per share outstanding during the quarter ended January 31, 2003 were not included in the computation of diluted income per share because the inclusion of such options would have been antidilutive.
Options to purchase 672,000 shares of common stock at a weighted average exercise price of $6.58 during the nine months ended January 31, 2004 and options to purchase 1,362,000 shares of common stock at a weighted average exercise price of $6.19 per share outstanding during the nine months ended January 31, 2003 were not included in the computation of diluted income per share because the inclusion of such options would have been antidilutive.
Note 3 Other comprehensive Income:
The components of other comprehensive income are presented in the following table (in thousands):
| Three Months Ended | Nine Months Ended | |||||||||||||||
| January 31, | January 31, | January 31, | January 31, | |||||||||||||
| 2004 | 2003 | 2004 | 2003 | |||||||||||||
Reported net income |
$ | 2,421 | $ | 314 | $ | 3,767 | $ | 2,317 | ||||||||
Other comprehensive income: |
||||||||||||||||
Unrealized (losses) gains on
available-for-sale
investments |
12 | 10 | (16 | ) | 10 | |||||||||||